melatonin has been researched along with Idiopathic Pulmonary Fibrosis in 3 studies
Idiopathic Pulmonary Fibrosis: A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosseinzadeh, A | 2 |
| Javad-Moosavi, SA | 2 |
| Reiter, RJ | 2 |
| Hemati, K | 1 |
| Ghaznavi, H | 2 |
| Mehrzadi, S | 2 |
| Zhao, X | 1 |
| Sun, J | 1 |
| Su, W | 1 |
| Shan, H | 2 |
| Zhang, B | 1 |
| Wang, Y | 1 |
| Shabanova, A | 1 |
| Liang, H | 1 |
| Yarahmadi, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Placebo-controlled Randomized Double-blind Trial of Melatonin in Outpatients With COVID-19 Infection[NCT04784754] | Phase 2 | 0 participants (Actual) | Interventional | 2021-04-01 | Withdrawn (stopped due to lack of subject enrollment) | ||
| A Pilot Placebo-controlled Randomized Double-blind Trial of Melatonin in Outpatients With COVID-19 Infection[NCT04474483] | Phase 2 | 8 participants (Actual) | Interventional | 2020-11-06 | Terminated (stopped due to difficult recruitment and complete first visit in person during thne hight of tne pandemic and later not enough subjects) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for melatonin and Idiopathic Pulmonary Fibrosis
| Article | Year |
|---|---|
Idiopathic pulmonary fibrosis (IPF) signaling pathways and protective roles of melatonin.
Topics: Animals; Antioxidants; Humans; Idiopathic Pulmonary Fibrosis; Melatonin; Protective Agents; Signal T | 2018 |
Oxidative/nitrosative stress, autophagy and apoptosis as therapeutic targets of melatonin in idiopathic pulmonary fibrosis.
Topics: Animals; Antioxidants; Apoptosis; Autophagy; Fibroblasts; Humans; Idiopathic Pulmonary Fibrosis; Mel | 2018 |
1 other study available for melatonin and Idiopathic Pulmonary Fibrosis
| Article | Year |
|---|---|
Melatonin Protects against Lung Fibrosis by Regulating the Hippo/YAP Pathway.
Topics: Adaptor Proteins, Signal Transducing; Animals; Bleomycin; Cell Cycle Proteins; Disease Models, Anima | 2018 |
Melatonin Protects against Lung Fibrosis by Regulating the Hippo/YAP Pathway.
Topics: Adaptor Proteins, Signal Transducing; Animals; Bleomycin; Cell Cycle Proteins; Disease Models, Anima | 2018 |
Melatonin Protects against Lung Fibrosis by Regulating the Hippo/YAP Pathway.
Topics: Adaptor Proteins, Signal Transducing; Animals; Bleomycin; Cell Cycle Proteins; Disease Models, Anima | 2018 |
Melatonin Protects against Lung Fibrosis by Regulating the Hippo/YAP Pathway.
Topics: Adaptor Proteins, Signal Transducing; Animals; Bleomycin; Cell Cycle Proteins; Disease Models, Anima | 2018 |